Basiswissen Hyposensibilisierung

Weiterführende Literatur

Mit freundlicher Genehmigung von „my-cme/arztCME“, der Online-Fortbildungsakademie für Fachberufe im Gesundheitswesen.

  • Bachert C, Lang B (1999) Histamine und Leukotriene bei der allergischen Rhinitis. Allergologie 8: 492-507
  • Bergmann RI et al. (1998) Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy 28: 965-70
  • Bolpacic J et al. (2006) Asthmavorstadium bei Patienten mit Rhinitis allergica. Allergologie. 29(7): 261-7
  • Bousquet J et al (1998) WHO Position Paper: Allergen immunotherapy. J Allergy Clin Immunol 53, Suppl. 44: 1-42
  • Des Roches A et al. (1997) IT with a standardized Der pter extract. SIT prevents the onset of new sensitiations in children. J Allergy Clin Immunol 99: 450-3
  • Durham SR, Kay AB (1985) Eosinophils, bronchial hyperreactivity and late phase asthmatic reaction. Clin Allergy 15: 411-8
  • Greisner WA et al. (1998) Co-existence of asthma and allergic rhinitis: A 23-year follow-up study of college students. Allergy Asthma Proc 19: 185-8
  • Gronberg H et al. (1993) Early and late nasal symptom response to allergen challenge. The effect of pretreatment with a glucocorticoid spray. Allergy 48: 87-93
  • Jacobsen L et al. (1996) IT as a preventive treatment. J Allergy Clin Immunol 97: 232-7
  • Kroegel C et al. (1999) Immunologische und molekulare Aspekte des Atemwegsremodelings beim Asthma bronchiale. Allergologie 10: 589-97
  • Leitlinie zur Diagnostik und Therapie von Asthma (Hrsg: Deutsche Atemwegsliga e.V. und Deutsche Gesellschaft für Pneumologie, Thieme Verlag, ISBN 3-13-133861-X)
  • Maly FE et al. (1997) Mononuclear blood cell suffidoleucotriene generation in the presence of interleukin-3 and whole blood histamine release in honey bee and yellow jacket venom allergy. J Invest Allergol Clin Immunol 7: 217-24
  • Martinez FD et al. (1995) Asthma and wheezing in the first six years of life. N Engl J Med 332: 133-8
  • Möller C et al. (2002) Pollenimmunotherapy reduces the development of asthma in children with seasonal rhonconjunctivitis (THe PAT-Study). J Allergy Clin Immunol 109: 251-6
  • Müller U, Mosbech H (1993) Position paper: Immunotherapy with Hymenoptera venoms. Allergy 48: 37-46
  • Nicolai T et al. (2003) Urban traffic and pollutant exposure related to respiratory outcomes and atopy in a large sample of children. Eur Respir J 21(6): 956-63
  • Numata T. et al. (1999) Pathophysiological features of the nasal mucosa in patients with idiopathic rhinitis compared to allergic rhinitis. Int Arch Allergy Immunol 119: 304-13
  • Ring J, Messmer K (1997) Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1: 466-8
  • Roberts G et al. (2006) Die Gräserpollen-Immuntherapie als wirksame therapeutische Option bei Kindern mit saisonalem allergischem Asthma Bronchiale. J Allergy Clin Immunol 117: 238-263
  • Sears MR (1998) Evolution of asthma through childhood. Clin Exp Allergy 28, Suppl 5: 82-9
  • Settipane RJ et al. (1994), Long-term risk factors for developing asthma and allergic rhinitis. Allergy Asthma Proc 15: 21-5
  • Sigurs N et al. (1995) Asthma and immunoglobulin antibodies after respiratory syncytial virus bronchiolitis. Pediatrics 95: 500-5
  • Spry CFJ (1988) Eosinophils. A comprehensive review and guide to the scientific and medical literature. Oxford: Oxford University Press
  • Strachan DP et al. (1997) Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: The international Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 8: 161-76
  • Straumann F et al. (1999) FEIA-Inhibition für die Indikationsstellung zur Hyposensibilisierung bei Doppelsenseibilisierung auf Bienen- und Wespengift. Allergologie, Suppl 2: 65
  • von Mutius E et al. (1994) Prevalence of asthma and atopy in two areas of West and East Germany. Am J Respir Crit Care Med 149: 358-64
  • Wang H et al. (2006) Doppelblinde, placebokontrollierte Studie zur Immuntherapie gegen Hausstaubmilben bei Asthmapatienten in China. Allergy 61: 191-197
  • Weiland (1999), Eur Resp J 14: 862
  • Weiss ST (1998) Environmental risk factors in childhood asthma. Clin Exp Allergy 28, Suppl 5: 29-34
  • Yuninger JW et al. (1992) A community based study on the epidemiology of asthma. Am Rev Resp Dis 146: 888-94
  • Bagnasco M et al. (1997) Absorption and distribution kinetics of the major Parietaria judaica allergen administered by noninjectable routes in healthy human beings. J Allergy Clin Immunol 100: 122-9
  • Bhattacharyya SP et al. (1998) Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J Leukoc Biol 63: 337-341
  • Bitter-Suermann D (1988) The anaphylatoxins. In: Rother K, Till G (eds.) The complement system. Berlin, Heidelberg, New York: Springer, 367-395
  • Burmester GP, Pezzuto A (1998) Taschenatlas der Immunologie. Stuttgart: Thieme
  • Coombs RRA, Gell PGH (1963) The classification of allergic reactions underlying disease. In: Clinical aspects of immunology. Philadelphia: Davis, 317
  • Ferrer M et al. (1996) Antigen-specific sulphidoleukotrien production and histaminerelease in pollinotic patients. J Invest Allergol Clin Immunol 6: 271-7
  • Foreman I (1987) Substance P and calcitonin gene-related peptide: Effects on mast cells in human skin. Int Arch Allergy Appl Immunol 82: 366-71
  • Franken HH et al. (1994) Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity. J Allergy Clin Immunol 93: 431-6
  • Galli SJ, Costa JJ (1995) Mast-cell-leukocyte cytokine cascades in allergic inflammation. Allergy 50: 851-62
  • Greaves MW, Wall PD (1996) Pathophysiology of itching. Lancet 348: 938-40
  • Holgate ST, Kapp A (1993) Allergy. London : Gower Medical Publishing
  • Johannson SGO, Bennich HH (1982) The clinical impact of the discovery of IgE. Ann Allergy 48: 325-30
  • Kapp A et al. (1985) Involvement of complement in psoriasis and atopic dermatitis – Measurement of C3a and C5a, C3, C4 and C1 inactivator. Arch Dermatol Res 277: 359-61
  • Kleine-Tebbe J et al. (2006) Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen. Leitlinie der DGAKI, ÄDA und GPA. Allergo J 15: 56-74
  • Kleinhans D, Zöllner I (2000) Therapiestudien zur sublingualen Immuntherapie mit Allergenen. Allergologie 7: 349-53
  • Malling H-J, Weeke B (1993) Immunotherapy. Position paper of the European Academy of Allergy and Clinical Immunology. Allergy 48: 9-35
  • Massey WA (1993) Pathogenesis and pharmacologic modulation of the cutaneous late-phase reaction. Ann Allergy 71: 578-84
  • Moingeon P et al. (2006) Immune mechanisms of allergen-specific sublingual immunotherapy, Review article. Allergy 61: 151-165
  • Norman PS, Lichtenstein LM (1978) The chemical and immunologic specificity of immunotherapy. J Allergy Clin Immunol 61: 370-7
  • Pearce FL (1991) Biological effects of histamine: An overview. Agents Actions 33: 4-7
  • Ring J (2004) Angewandte Allergologie. 3. Aufl, Urban & Vogel Verlag, München
  • White M (1999) Mediators of inflammation and the inflammatory process. J Allergy Clin Immunol 103: 378-81

Aktuelles aus der Themenwelt

Sind Allergiker besonders ängstlich?

Eine aktuelle Studie der Technischen Universität München (TUM) konnte zeigen, dass saisonale Allergien z. B. gegen Gräser oder Pollen bei Menschen mit Angststörungen vermehrt auftreten, während Depressive öfter unter ganzjährigen Allergien leiden. Nahrungsmittel- oder...

mehr lesen


Blogarchiv